11:48 AM EST - Bioniche Life Sciences Inc. : announced that The Journal of Urology has accepted for publication a manuscript entitled: Efficacy and Safety of MCNA in Patients with Non-Muscle Invasive Bladder Cancer at High-Risk of Recurrence and Progression Who Have Failed Treatment with Bacillus Calmette-Guérin. Bioniche Life Sciences Inc.
shares T.BNC are trading up $0.005 at $0.23.
